Nurix Therapeutics (NRIX)
(Delayed Data from NSDQ)
$24.47 USD
-0.11 (-0.45%)
Updated Nov 1, 2024 04:00 PM ET
After-Market: $24.50 +0.03 (0.12%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth A Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 2/20/25 |
---|---|
Current Quarter | -0.67 |
EPS Last Quarter | -0.67 |
Last EPS Surprise | 0.00% |
ABR | 1.27 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -2.84 |
Next Year | -2.68 |
EPS (TTM) | -2.91 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (11/2024) |
Next Qtr (2/2025) |
Current Year (11/2024) |
Next Year (11/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 17.15M | 14.55M | 54.11M | 66.93M |
# of Estimates | 6 | 3 | 8 | 7 |
High Estimate | 22.90M | 15.00M | 64.17M | 80.40M |
Low Estimate | 13.50M | 13.75M | 41.00M | 55.00M |
Year ago Sales | 15.16M | 16.59M | 76.99M | 54.11M |
Year over Year Growth Est. | 13.13% | -12.30% | -29.72% | 23.71% |
Earnings Estimates
Current Qtr (11/2024) |
Next Qtr (2/2025) |
Current Year (11/2024) |
Next Year (11/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.67 | -0.69 | -2.84 | -2.68 |
# of Estimates | 8 | 3 | 9 | 9 |
Most Recent Consensus | -0.67 | -0.67 | -2.80 | -2.81 |
High Estimate | -0.51 | -0.67 | -2.61 | -1.92 |
Low Estimate | -0.88 | -0.73 | -3.14 | -2.92 |
Year ago EPS | -0.77 | -0.76 | -2.65 | -2.84 |
Year over Year Growth Est. | 12.99% | 9.21% | -7.17% | 5.48% |
Agreement - Estimate Revisions
Current Qtr (11/2024) |
Next Qtr (2/2025) |
Current Year (11/2024) |
Next Year (11/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 6 | 3 | 4 | 4 |
Up Last 60 Days | 6 | 3 | 4 | 4 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 0 | 3 | 2 |
Down Last 60 Days | 1 | 0 | 3 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (11/2024) |
Next Qtr (2/2025) |
Current Year (11/2024) |
Next Year (11/2025) |
|
---|---|---|---|---|
Current | -0.67 | -0.69 | -2.84 | -2.68 |
7 Days Ago | -0.67 | -0.69 | -2.84 | -2.68 |
30 Days Ago | -0.72 | -0.79 | -2.86 | -2.73 |
60 Days Ago | -0.72 | -0.79 | -2.86 | -2.73 |
90 Days Ago | -0.72 | -0.79 | -2.85 | -2.74 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (11/2024) |
Next Qtr (2/2025) |
Current Year (11/2024) |
Next Year (11/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.67 | -0.69 | -2.80 | -2.76 |
Zacks Consensus Estimate | -0.67 | -0.69 | -2.84 | -2.68 |
Earnings ESP | 0.00% | 0.00% | 1.32% | -2.82% |
Surprise - Reported Earnings History
Quarter Ending (8/2024) |
Quarter Ending (5/2024) |
Quarter Ending (2/2024) |
Quarter Ending (11/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.67 | -0.71 | -0.76 | -0.77 | NA |
Estimate | -0.67 | -0.66 | -0.80 | -0.51 | NA |
Difference | 0.00 | -0.05 | 0.04 | -0.26 | -0.07 |
Surprise | 0.00% | -7.58% | 5.00% | -50.98% | -13.39% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more